Coating material for improving bioactivity of PEEK bone implantation model and preparation method
The hydroxyapatite coating prepared by PEEK and nano-hydroxyapatite composite materials and sol-gel method combined with spraying method and heat treatment technology has solved the problem of insufficient biological activity of PEEK bone implant materials, significantly improving bone transplantation The biological activity and interface strength of the model achieve excellent biocompatibility and mechanical stability.
Patent Information
- Application Number
- CN202411200019.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-29
- Publication Date
- 2024-12-06
AI Technical Summary
The lack of biological activity of PEEK bone implant materials in the field of biomedical sciences leads to insufficient binding of the implant to the surrounding bone tissue, limiting its performance during bone integration.
By mixing PEEK with nano-hydroxyapatite (n-HA) to form a composite material, and the hydroxyapatite coating material is prepared by sol-gel method, combining spraying method and heat treatment technology to enhance the combination of coating and substrate. Force and stability.
The bioactivity and interface strength of the PEEK bone implant model are significantly improved, the adhesion of the coating and the stability of the overall structure are enhanced, and excellent biocompatibility, mechanical stability and long-term durability are provided.
Smart Images

Figure CN119075006A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biomedicine, and in particular to a coating material for improving the biological activity of a PEEK bone implant model and a preparation method thereof. Background Art
[0002] Polyetheretherketone (PEEK), as a high-performance engineering plastic, is widely used in aerospace, automobile manufacturing, medical devices and other fields due to its excellent mechanical properties, chemical corrosion resistance, heat resistance and good processing performance.
[0003] Especially in the biomedical field, PEEK's biological inertness, low friction coefficient and compatibility with human bone tissue make it one of the important choices for bone implant materials.
[0004] In the biomedical field, PEEK is considered for use as a bone implant material due to its bioinertness, low coefficient of friction, and compatibility with human bone tissue.
[0005] However, the biological inertness of PEEK also means that its biological activity is insufficient, which limits its performance during bone integration and results in a weak bond between the implant and the surrounding bone tissue.
[0006] Therefore, it is necessary to provide a coating material and a preparation method for improving the bioactivity of a PEEK bone implant model to solve the above technical problems. Summary of the invention
[0007] The invention overcomes the shortcomings of the prior art and provides a coating material and a preparation method for improving the biological activity of a PEEK bone implant model.
[0008] To achieve the above object, the technical solution adopted by the present invention is: a coating material and a preparation method for improving the biological activity of a PEEK bone implant model, comprising the following steps:
[0009] S1: preparing PEEK material and performing modification treatment, firstly, the PEEK raw material is mixed with nano-hydroxyapatite (n-HA) by melt blending method to form a reinforced composite material;
[0010] S2: preparing hydroxyapatite (HA) coating material, dissolving calcium source and phosphorus source by sol-gel method and reacting to generate sol, and then gelling, drying and high-temperature calcination to finally obtain well-crystallized HA powder;
[0011] S3: The melt-blended PEEK / n-HA composite material is processed into a desired model shape by injection molding, and then trimmed, polished and cleaned to ensure that the model surface is flat and free of defects;
[0012] S4: The HA powder bioactive coating material is evenly coated on the surface of the PEEK / n-HA composite material model by spraying;
[0013] S5: The coated PEEK / n-HA composite material model is cured by heat treatment to enhance the bonding strength between the coating and the substrate and the stability of the coating.
[0014] In a preferred embodiment of the present invention, in said S1, the purity of the PEEK raw material is 99%.
[0015] In a preferred embodiment of the present invention, in S1, the mass ratio of PEEK to nano-hydroxyapatite (n-HA) is in the range of 20:1-5:1.
[0016] In a preferred embodiment of the present invention, in S1, the mixing time of PEEK and n-HA is in the range of 30-10 min, and the mixing temperature is in the range of 340-380°C.
[0017] In a preferred embodiment of the present invention, in S2, the mass ratio of the calcium source to the phosphorus source is in the range of 1.5:1-2.5:1.
[0018] In a preferred embodiment of the present invention, in S2, the high temperature calcination temperature ranges from 600 to 900°C, and the drying time ranges from 20 to 30 hours.
[0019] In a preferred embodiment of the present invention, in said S4, the particle size of the HA powder used in the spraying method is in the range of 1-10 μm.
[0020] In a preferred embodiment of the present invention, in said S4, the spraying speed of the spraying method is in the range of 10-50 cm / s, and the spraying distance is 10-30 cm.
[0021] In a preferred embodiment of the present invention, in S5, the curing temperature range of the curing treatment is 100°C to 300°C, and the curing time range is 10-20h.
[0022] In a preferred embodiment of the present invention, in S5, gradient temperature control is adopted during the curing process to gradually increase the temperature to the highest curing temperature.
[0023] The present invention solves the defects existing in the background technology and has the following beneficial effects:
[0024] (1) The present invention provides a coating material and a preparation method for improving the bioactivity of a PEEK bone implant model. The mixing of PEEK and nanohydroxyapatite (n-HA) in step S1 and the gradient temperature curing treatment in step S5 significantly improve the bonding strength between the coating and the PEEK substrate. In step S1, the mass ratio of PEEK to n-HA (20:1 to 5:1) ensures the uniformity of the composite material and enhances the mechanical locking of the interface. The heat treatment curing process in step S5 promotes the chemical bonding between the coating and the substrate by gradually increasing the temperature to the highest curing temperature, thereby enhancing the adhesion of the coating and the stability of the overall structure.
[0025] (2) The coating material and preparation method of the present invention pay special attention to improving the biological activity of the PEEK bone implant model. The hydroxyapatite (HA) coating material prepared by the sol-gel method in step S2 has good biocompatibility and bone integration ability because its chemical composition and crystal structure are similar to human bone tissue; in addition, the particle size of the HA powder sprayed in step S4 is controlled within the range of 1-10 μm, which facilitates effective contact and cell response between the coating and biological tissue.
[0026] (3) The preparation method of the present invention achieves a comprehensive improvement in the performance of the PEEK bone implant model by controlling the key parameters in each step; the strict control of the mixing time and temperature of PEEK and n-HA in step S1, and the precise mass ratio of the calcium source and the phosphorus source in step S2 ensure the high quality of the composite material and the HA coating material; the surface treatment process in step S3 ensures the high flatness of the model surface and provides an ideal substrate for the uniform adhesion of the coating; and provides the PEEK bone implant model with excellent comprehensive performance, including biocompatibility, mechanical stability and long-term durability. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art are briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present invention. For those of ordinary skill in the art, other drawings can be obtained based on these drawings without creative work.
[0028] Figure 1 It is a flow chart of a preferred embodiment of the present invention. DETAILED DESCRIPTION
[0029] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0030] In the following description, many specific details are set forth to facilitate a full understanding of the present invention, but the present invention can also be implemented in other ways different from those described herein. Therefore, the protection scope of the present invention is not limited to the specific embodiments disclosed below.
[0031] like Figure 1 As shown, the present invention provides a coating material and a preparation method for improving the biological activity of a PEEK bone implant model, comprising the following steps:
[0032] S1: PEEK material is prepared and modified. First, the PEEK raw material is mixed with nano-hydroxyapatite (n-HA) by melt blending. The purity of the PEEK raw material is 99%. The mass ratio of PEEK to nano-hydroxyapatite (n-HA) is in the range of 20:1-5:1. The mixing time of PEEK and n-HA is in the range of 30-10min, and the mixing temperature is in the range of 340-380℃ to form a reinforced composite material.
[0033] S2: Prepare hydroxyapatite (HA) coating material. The calcium source and phosphorus source are dissolved and reacted to form a sol by a sol-gel method, and then subjected to gelation, drying and high-temperature calcination treatment. The mass ratio of the calcium source and the phosphorus source is in the range of 1.5:1-2.5:1, the high-temperature calcination temperature range is 600-900℃, and the drying time range is 20-30h. Finally, well-crystallized HA powder is obtained. The calcium source and the phosphorus source are calcium chloride and diammonium hydrogen phosphate, respectively.
[0034] S3: The melt-blended PEEK / n-HA composite material is processed into the desired model shape by injection molding, and then trimmed, polished and cleaned to ensure that the model surface is flat and defect-free.
[0035] S4: The HA powder bioactive coating material is evenly coated on the surface of the PEEK / n-HA composite material model by spraying. The HA powder particle size range used in the spraying method is 1-10μm, the spraying speed range is 10-50cm / s, and the spraying distance is 10-30cm:
[0036] S5: The coated PEEK / n-HA composite material model is cured by heat treatment. Gradient temperature control is used during the curing process to gradually increase the temperature to the maximum curing temperature. The curing temperature range of the curing treatment is 100°C to 300°C, and the curing time range is 10-20h to enhance the bonding strength between the coating and the substrate and the stability of the coating.
[0037] It should be noted that:
[0038] Step S1: By using 99% high-purity PEEK raw materials and mixing them with nano-hydroxyapatite (n-HA), uniform dispersion and optimized biocompatibility of the composite material were achieved. The mixing time was controlled at 30-10min and the mixing temperature was controlled at 340-380℃ to ensure the uniformity of the material and prevent decomposition, thereby preparing a PEEK / n-HA composite material with enhanced mechanical properties and expected good cell response.
[0039] Step S2: The hydroxyapatite (HA) coating material is prepared by the sol-gel method. By controlling the mass ratio of the calcium source and the phosphorus source at 1.5:1-2.5:1, as well as high-temperature calcination and appropriate drying time, HA powder with uniform chemical composition and complete crystal structure is obtained, laying the foundation for the formation of a highly bioactive coating.
[0040] Step S3: The PEEK / n-HA composite material is molded by injection molding and then goes through surface treatment processes such as trimming, grinding and cleaning to ensure the high flatness and defect-freeness of the model surface, providing an ideal substrate for uniform adhesion of the coating.
[0041] Step S4: HA powder with uniform particle size (1-10 μm) is evenly coated on the model surface by spraying. By controlling the spraying speed and distance, a uniform, continuous and highly adhesive bioactive coating is formed.
[0042] Step S5: The gradient temperature-controlled heat treatment curing method not only releases the stress of the coating material and reduces the risk of cracking, but also promotes the full cross-linking and curing of the coating material through a curing temperature of 100-300°C and a curing time of 10 to 20 hours, significantly improving the mechanical strength, durability and bonding strength of the coating with the PEEK substrate, thereby enhancing the mechanical stability and long-term performance of the overall implant model.
[0043] In summary, each step from S1 to S5 is designed to improve the bioactivity of the PEEK bone implant model and the interface strength between the coating and the substrate. Through the comprehensive application of these steps, a PEEK bone implant model with excellent biocompatibility, mechanical properties and stability can be prepared.
[0045] Embodiment 1:
[0046] S1: Weigh 100 g of 99% pure PEEK raw material and 5 g of n-HA; mix the PEEK raw material and n-HA in a mixer at 350°C for 30 min to ensure that the materials are evenly mixed and there is no decomposition; after mixing, obtain a PEEK / n-HA composite material, perform preliminary cooling and prepare for the next step of processing.
[0047] S2: 10 g of calcium chloride and 6.67 g of diammonium hydrogen phosphate were weighed according to a molar ratio of 1.5:1; the calcium chloride and diammonium hydrogen phosphate were dissolved in a sufficient amount of distilled water to perform a sol-gel reaction to generate a sol; the sol was gelled at room temperature for 24 hours, and then dried at 80°C until a dry gel was formed; the dried gel was calcined at a high temperature of 750°C for 2 hours to obtain a well-crystallized HA powder.
[0048] S3: The PEEK / n-HA composite material obtained in step S1 is injection molded to form the desired bone implant model shape; the processed model is trimmed to remove burrs and uneven edges, and polished with 800-grit sandpaper to ensure high flatness of the model surface; the model is cleaned in ethanol with an ultrasonic cleaner for 5 minutes to remove surface residues and impurities.
[0049] S4: Adjust the spraying equipment to ensure that the spraying speed is controlled at 30 cm / s and the spraying distance is maintained at 20 cm; spray the HA powder obtained in step S2 with a particle size of 5 μm and evenly cover the surface of the PEEK / n-HA composite material model treated in step S3.
[0050] S5; placing the model coated in step S4 in a heat treatment furnace, and using gradient temperature control technology to gradually increase the temperature from room temperature to the maximum curing temperature of 200°C; during the heating process, the heating rate is controlled to be 5°C / min to ensure that the stress of the coating material is released and reduce the risk of cracking; maintaining the temperature at 200°C for 15 hours to complete the curing treatment and ensure sufficient cross-linking and curing of the coating material; after the curing is completed, take out the model and naturally cool it to room temperature to obtain the final PEEK bone implant model.
[0051] Comparative Example 1 (Changing the Ratio of PEEK to n-HA)
[0052] This comparative example 1 is basically the same as the embodiment 1, except that:
[0053] S1': 100 g of 99% pure PEEK raw material was weighed, but only 2.5 g of n-HA was weighed this time, so that the mass ratio of PEEK to n-HA was adjusted to 40:1, which is much lower than 20:1 in Example 1.
[0054] Comparative Example 2 (Omitting the addition of n-HA)
[0055] This comparative example 2 is basically the same as the example 1, except that:
[0056] S1”: Only 100 g of 99% pure PEEK raw material was used without any n-HA added.
[0057] Comparative Example 3 (Variation of the Particle Size of HA Coating)
[0058] This comparative example 3 is basically the same as the embodiment 1, except that:
[0059] S4': The HA powder obtained in step S2 is sprayed with a particle size of 50 μm, which is significantly larger than the particle size of 5 μm in Example 1.
[0060] Experiment 1:
[0061] Biological activity test
[0062] Bioactivity testing of the final PEEK bone implant model's response in vivo and its ability to promote tissue growth involves the following steps:
[0063] Implantation experiment: The final PEEK bone implant model was implanted into the bone defect site of the animal model.
[0064] Observation time points: The implants were removed after specific time points (4 weeks, 8 weeks, 12 weeks).
[0065] Histological analysis: Masson's trichrome staining was used to observe new bone formation and the response of surrounding tissues.
[0066] Histomorphometric analysis: The percentage of new bone area to the total observation area was quantitatively analyzed to evaluate the degree of bone integration.
[0067] Table 1:
[0068]
[0069]
[0070] From Table 1 we can see that:
[0071] The bioactivity test evaluated the ability of the PEEK bone implant model to promote tissue growth in vivo. The results showed that over time, the degree of bone integration of all models increased, but the degree of bone integration of Example 1 was higher than that of Comparative Examples 1, 2 and 3 at all time points.
[0072] Example 1: The degree of bone integration was 55.45% after 4 weeks, 75.25% after 8 weeks, and 89.90% after 12 weeks, showing that the degree of bone integration increased significantly over time, indicating that the model has good biological activity and the ability to promote bone growth.
[0073] Comparative Example 1: The degree of bone integration is low, which is due to the relatively low quality of PEEK and n-HA, resulting in reduced biological activity.
[0074] Comparative Example 2: Due to the lack of n-HA, the degree of bone integration is further reduced, indicating that n-HA is necessary to improve biological activity.
[0075] Comparative Example 3: The degree of bone integration is the lowest, which indicates that the particle size of the HA coating has a significant effect on the biological activity, and a smaller particle size (such as Example 1) is more conducive to bone integration.
[0076] Experiment 2:
[0077] Interface strength test:
[0078] Push-pull test: The bonding strength between the coating and the substrate is determined by applying force perpendicular to the coating surface.
[0079] Shear test: Shear force is applied parallel to the coating surface to simulate the forces encountered in actual use.
[0080] Maximum load recording: Record the maximum load that causes the coating to separate from the substrate.
[0081] Failure Mode Analysis: Observe and record the mode of separation of the coating from the substrate, such as fracture within the coating, substrate fracture, or interface detachment.
[0082] Table 2:
[0083]
[0084] From Table 2 we can see that:
[0085] The interface strength test evaluated the bonding strength between the coating and the PEEK substrate. The results of both the push-pull test and the shear test showed that Example 1 had the highest bonding strength, which was attributed to the optimized PEEK to n-HA ratio and coating particle size.
[0086] Example 1: The push-pull test result is 3489.74N, and the shear test result is 1998.95N, showing a strong interface bonding strength.
[0087] Comparative Example 1: The bonding strength is low because the reduction in the ratio of PEEK to n-HA affects the bonding between the coating and the substrate.
[0088] Comparative Example 2: Due to the lack of n-HA, the interface strength is further reduced, indicating that n-HA is important for enhancing the interface strength.
[0089] Comparative Example 3 has the largest coating particle size, but its interface strength is the lowest, which indicates that too large a coating particle size will affect the bonding effect between the coating and the substrate.
[0090] Experiment 3:
[0091] Microstructure Analysis:
[0092] Scanning electron microscopy (SEM): observe the microscopic morphology, porosity and surface roughness of the coating.
[0093] Energy Dispersive Spectroscopy (EDS): Determines the distribution and chemical composition of elements in the coating.
[0094] X-ray Diffraction (XRD): Analyze the crystal structure and phase purity of the coating to understand the crystal phase that affects the material's stability and biocompatibility.
[0095] Coating uniformity score: Based on the SEM images, the uniformity of the coating was scored (1-10).
[0096] Table 3:
[0097] Interface strength test Embodiment 1 Comparative Example 1 Comparative Example 2 Comparative Example 3 Coating uniformity 8.50 6.75 5.00 4.25 Crystal integrity 9.00 7.00 6.00 5.00
[0098] From Table 3 we can see that:
[0099] Microstructural analysis evaluated the coating's uniformity and crystalline integrity, factors that are critical to the material's stability and biocompatibility.
[0100] Example 1: The coating uniformity score was 8.50, and the crystal integrity score was 9.00, indicating that the coating had good uniformity and crystal structure.
[0101] Comparative Example 1: The coating uniformity and crystal integrity scores were lower, which was due to the change in the ratio of PEEK to n-HA affecting the microstructure of the coating.
[0102] Comparative Example 2: The lack of n-HA resulted in further reductions in coating uniformity and crystal integrity scores.
[0103] Comparative Example 3: The increase in coating particle size leads to a decrease in coating uniformity score, which indicates that the coating particle size has a significant effect on the microstructure of the coating
[0104] In summary:
[0105] Based on the results of Experiments 1, 2, and 3, the following conclusions were drawn: The bioactivity and interface strength of the PEEK bone implant model can be effectively improved by controlling the ratio of PEEK to n-HA, the particle size of the HA coating, and adopting appropriate heat treatment processes.
[0106] In the bioactivity test, Example 1 showed a significantly improved degree of bone integration over time: 55.45% after 4 weeks, 75.25% after 8 weeks, and 89.90% at 12 weeks, which was significantly better than Comparative Examples 1, 2, and 3. This result emphasizes the importance of adding an appropriate amount of n-HA to improve the biocompatibility of PEEK.
[0107] In the interface strength test, the push-pull test and shear test results of Example 1 were 3489.74 N and 1998.95 N, respectively, which were significantly higher than those of other comparative examples. This confirms that the appropriate ratio of PEEK to n-HA and the 5 μm HA coating particle size play a key role in improving the bonding strength between the coating and the substrate.
[0108] Microstructure analysis further showed that the coating uniformity and crystal integrity scores of Example 1 were 8.50 and 9.00, respectively, which were much higher than those of the comparative example. The SEM and XRD analysis results revealed the positive effects of optimizing coating parameters on the microstructure of the material. These findings indicate that Example 1 exhibits the best overall performance with its optimized formulation and process parameters, providing strong support for further research and clinical application of PEEK bone implant models.
[0109] The above is based on the ideal embodiment of the present invention. Through the above description, relevant personnel can make various changes and modifications without departing from the technical concept of the present invention. The technical scope of the present invention is not limited to the content in the specification, but must be determined according to the scope of the claims.
Claims
1. A coating material and preparation method for improving the biological activity of a PEEK bone implant model, characterized in that: The following steps are involved: S1: preparing PEEK material and performing modification treatment, firstly, the PEEK raw material is mixed with nano-hydroxyapatite (n-HA) by melt blending method to form a reinforced composite material; S2: preparing hydroxyapatite (HA) coating material, dissolving calcium source and phosphorus source by sol-gel method and reacting to generate sol, and then gelling, drying and high-temperature calcination to finally obtain well-crystallized HA powder; S3: The melt-blended PEEK / n-HA composite material is processed into a desired model shape by injection molding, and then trimmed, polished and cleaned to ensure that the model surface is flat and free of defects; S4: The HA powder bioactive coating material is evenly coated on the surface of the PEEK / n-HA composite material model by spraying; S5: The coated PEEK / n-HA composite material model is cured by heat treatment to enhance the bonding strength between the coating and the substrate and the stability of the coating.
2. A coating material and preparation method for improving the biological activity of a PEEK bone implant model according to claim 1, characterized in that: In the S1, the purity of the PEEK raw material is 99%.
3. A coating material and preparation method for improving the biological activity of a PEEK bone implant model according to claim 1, characterized in that: In the S1, the mass ratio of PEEK to nano-hydroxyapatite (n-HA) is in the range of 20:1-5:
1.
4. A coating material and preparation method for improving the biological activity of a PEEK bone implant model according to claim 1, characterized in that: In the S1, the mixing time of PEEK and n-HA is in the range of 30-10 min, and the mixing temperature is in the range of 340-380°C.
5. A coating material and preparation method for improving the biological activity of a PEEK bone implant model according to claim 1, characterized in that: In the S2, the mass ratio of the calcium source to the phosphorus source is in the range of 1.5:1-2.5:
1.
6. A coating material and preparation method for improving the biological activity of a PEEK bone implant model according to claim 1, characterized in that: In the step S2, the high temperature calcination temperature ranges from 600 to 900°C, and the drying time ranges from 20 to 30 hours.
7. A coating material and preparation method for improving the biological activity of a PEEK bone implant model according to claim 1, characterized in that: In S4, the HA powder used in the spraying method has a particle size range of 1-10 μm.
8. The coating material and preparation method for improving the biological activity of a PEEK bone implant model according to claim 1, characterized in that: In the S4, the spraying speed of the spraying method ranges from 10 to 50 cm / s, and the spraying distance ranges from 10 to 30 cm.
9. The coating material and preparation method for improving the biological activity of a PEEK bone implant model according to claim 1, characterized in that: In the S5, the curing temperature of the curing treatment is in the range of 100°C to 300°C, and the curing time is in the range of 10-20 hours.
10. The coating material and preparation method for improving the biological activity of a PEEK bone implant model according to claim 1, characterized in that: In S5, gradient temperature control is adopted during the curing process to gradually increase the temperature to the highest curing temperature.
